CJC-1295 w/ DAC 5MG, also known as DAC:GRF, is a synthetic peptide developed for controlled laboratory research. Researchers study this compound to examine extended peptide activity and sustained signaling behavior enabled by its Drug Affinity Complex modification.

• DAC-modified peptide studied for prolonged activity in research settings
• Drug Affinity Complex supports extended peptide interaction under laboratory conditions
• Supplied in lyophilized form for consistent preparation and repeatable research workflows